Levitra
Product Images NDC 43353-323

9 FDA label images from Aphena Pharma Solutions - Tennessee, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levitra (NDC 43353-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vardenafil HCl (levitra) 5mg Tablets (43353 323)

Vardenafil HCl (levitra) 5mg Tablets (43353 323)
Label for Levitra with active ingredient Vardenafil HCl 5mg in tablet form, containing 2 tablets. The label includes barcodes, storage instructions, and manufacturer info, indicating Bayer Corporation in Germany as manufacturer and repackaging by Aphena Pharma Solutions, Tennessee, Inc. It is marked RX Only.*
FDA Label Image

Structural Formula (Bfc7a65d 372d 4748 8bb9 C5467a87207c 01)

Structural Formula (Bfc7a65d 372d 4748 8bb9 C5467a87207c 01)
Chemical structure of the active ingredient in Levitra, showing its molecular composition including labeled atoms and functional groups.*
FDA Label Image

Figure 1 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 02)

Figure 1 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 02)
A line graph showing plasma concentration (µg/L) of Levitra over 24 hours. The x-axis represents time in hours, and the y-axis shows plasma concentration with error bars indicating variability. The graph depicts a peak concentration followed by a gradual decline to near zero by 24 hours.*
FDA Label Image

Figure 2 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 03)

Figure 2 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 03)
This image contains three line graphs showing mean material change over time. The first graph plots systolic blood pressure changes in mmHg, the second shows diastolic blood pressure changes in mmHg, and the third depicts heart rate changes in bpm. The x-axis represents timing of Vardenafil treatment relative to pre-NTG at intervals of 24h, 8h, 4h, and 1h.*
FDA Label Image

Figure 3 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 04)

Figure 3 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 04)
A line graph displaying mean change in mmHg over time in hours for Levitra (Vardenafil) 5 mg and 6 mg compared to placebo. The graph includes data for simultaneous and 6-hour separation dosing, showing trends for each group from 0 to 6 hours post-dose.*
FDA Label Image

Figure 4 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 05)

Figure 4 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 05)
A line graph depicting mean change in mmHg over time (hours) for two treatments: Placebo and Vardenafil 5 mg. The graph includes separate lines for simultaneous and 8-hour separated dosing, showing blood pressure change trends for Levitra's active ingredient Vardenafil compared to placebo.*
FDA Label Image

Figure 5 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 06)

Figure 5 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 06)
A line chart depicting mean change in mmHg (millimeters of mercury) over time in hours for different treatments. The graph compares Placebo (Stage 1 and Stage 2) with Vardenafil 10 mg and 20 mg. The data points represent mean changes, showing how blood pressure changes over a 6-hour period for each group.*
FDA Label Image

Figure 6 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 07)

Figure 6 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 07)
A line graph labeled Terazosin showing mean change in mmHg over 6 hours. The graph compares placebo and varying doses of Vardenafil and their mean blood pressure changes under 8-hour separation and simultaneous conditions.*
FDA Label Image

Figure 7 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 08)

Figure 7 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 08)
A line graph titled 'TAMSULOSIN' depicting mean change (mmHg) over time (hours) for different treatments involving placebo and 10 mg or 20 mg Vardenafil in either 6hr separation or simultaneous administration with or without Cinitrusone. The x-axis represents time in hours from 0 to 6, and the y-axis represents mean change in mmHg from -10 to 10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.